Johannan F. Brandse

Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis

Johannan F. Brandse, Gijs R. van den Brink, Manon E. Wildenberg et al. · Gastroenterology · 2015 · 421 citations

Pharmacy, Immunology, Pharmacotherapy +14

Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis

Johannan F. Brandse, Ron A. A. Mathôt, Desirée van der Kleij et al. · Clinical Gastroenterology and Hepatology · 2015 · 197 citations

Medicine, Pharmacokinetics, Pharmacology +16

Development of Reliable, Valid and Responsive Scoring Systems for Endoscopy and Histology in Animal Models for Inflammatory Bowel Disease

Pim J. Koelink, Manon E. Wildenberg, Larry Stitt et al. · Journal of Crohn s and Colitis · 2018 · 175 citations · Full text

Veterinary Medicine, Pathobiology, Pathology +16

A Real-life Population Pharmacokinetic Study Reveals Factors Associated with Clearance and Immunogenicity of Infliximab in Inflammatory Bowel Disease

Johannan F. Brandse, Diane R. Mould, Oscar S. Smeekes et al. · Inflammatory Bowel Diseases · 2017 · 147 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

Efficacy of dashboard driven dosing of infliximab in inflammatory bowel disease patients; a randomized controlled trial

Anne S. Strik, Mark Löwenberg, Diane R. Mould et al. · Scandinavian Journal of Gastroenterology · 2020 · 118 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17